| Identification | Back Directory | [Name]
GSK717 | [CAS]
1595278-21-9 | [Synonyms]
GSK717
1H-Benzimidazole-1-acetamide, 2-[2-(benzoylmethylamino)ethyl]-N-(2,3-dihydro-1H-inden-5-yl)- | [Molecular Formula]
C28H28N4O2 | [MDL Number]
MFCD32671947 | [MOL File]
1595278-21-9.mol | [Molecular Weight]
452.56 |
| Chemical Properties | Back Directory | [Boiling point ]
731.6±60.0 °C(Predicted) | [density ]
1.23±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 250 mg/mL (552.43 mM) | [form ]
Solid | [pka]
14.05±0.20(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
GSK717 is a potent, selective NOD2 (nucleotide-binding oligomerization domain 2) inhibitor. GSK717 inhibits muramyl dipeptide (MDP)-induced NOD2-mediated signaling, with an IC50 of 400 nM for MDP-stimulated IL-8 secretion in HEK293/hNOD2 cells[1]. | [Biological Activity]
Cell permeable: yes''Primary Target
NOD2''Reversible: yes''Target IC50: 400 nM for MDP-stimulated IL-8 secretion in HEK293/hNOD2 cells | [References]
[1] Rickard DJ, et al. Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway. PLoS One. 2013;8(8):e69619. Published 2013 Aug 1. DOI:10.1371/journal.pone.0069619 |
|
|